1. Low seroprevalence of COVID-19 in Lao PDR, late 2020
- Author
-
Darouny Phonekeo, Thierry Rose, Sengchanh Kounnavong, Somphavanh Somlor, Nicolas Escriou, Khamsing Vongphayloth, Somphou Sayasone, Mayfong Mayxay, Vilaysone Khounvisith, Phonepadith Xangsayarath, Siriphone Virachith, Antony P. Black, Paul T. Brey, Elodie Calvez, Marc Eloit, Virginie Pommelet, Vincent Lacoste, Judith M. Hübschen, Sarah Temmam, Institut Pasteur du Laos, Réseau International des Instituts Pasteur (RIIP), Lao Tropical Public Health Institute, Institute of Research and Education Development [Vientiane, Laos] (IRED), University of Health Sciences [Vientiane, Laos] (UHS)-Ministry of Health [Laos], Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahidol University [Bangkok]-Mahosot Hospital, Centre for Tropical Medicine and Global Health [Oxford, UK], Nuffield Department of Medicine [Oxford, UK] (Big Data Institute), University of Oxford-University of Oxford, National Centre for Laboratory and Epidemiology [Vientiane, Laos], Découverte de pathogènes – Pathogen discovery, Institut Pasteur [Paris] (IP), Département de Santé Globale - Department Global Health, Biologie Cellulaire des Lymphocytes - Lymphocyte Cell Biology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Luxembourg Institute of Health (LIH), Agence Française de Développement. Additional, Institut Pasteur du Laos, Institute Pasteur, Paris and Luxembourg Ministry of Foreign and European Affairs ('PaReCIDS II')., and TEMMAM, Sarah
- Subjects
[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Health Policy ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,Age and sex ,Article ,Psychiatry and Mental health ,Infectious Diseases ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Pediatrics, Perinatology and Child Health ,Internal Medicine ,Medicine ,Seroprevalence ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Christian ministry ,Geriatrics and Gerontology ,Public aspects of medicine ,RA1-1270 ,business ,Demography - Abstract
Background In 2020 Lao PDR had low reported COVID-19 cases but it was unclear whether this masked silent transmission. A seroprevalence study was done August - September 2020 to determine SARS-CoV-2 exposure. Methods Participants were from the general community (n=2433) or healthcare workers (n=666) in five provinces and bat/wildlife contacts (n=74) were from Vientiane province. ELISAs detected anti- SARS-CoV-2 Nucleoprotein (N; n=3173 tested) and Spike (S; n=1417 tested) antibodies. Double-positive samples were checked by IgM/IgG rapid tests. Controls were confirmed COVID-19 cases (n=15) and pre-COVID-19 samples (n=265). Seroprevalence for the general community was weighted to account for complex survey sample design, age and sex. Findings In pre-COVID-19 samples, 5·3%, [95% CI=3·1-8·7%] were anti-N antibody single-positive and 1·1% [0·3-3·5%] were anti-S antibody single positive. None were double positive. Anti-N and anti-S antibodies were detected in 5·2% [4·2-6·5%] and 2·1% [1·1-3·9%] of the general community, 2·0% [1·1-3·3%] and 1·4% [0·5-3·7%] of healthcare workers and 20·3% [12·6-31·0%] and 6·8% [2·8-15·3%] of bat/wildlife contacts. 0·1% [0·02-0·3%] were double positive for anti-N and anti-S antibodies (rapid test negative). Interpretation We find no evidence for significant SARS-CoV-2 circulation in Lao PDR before September 2020. This likely results from early decisive measures taken by the government, social behavior, and low population density. High anti-N /low anti-S seroprevalence in bat/wildlife contacts may indicate exposure to cross-reactive animal coronaviruses with threat of emerging novel viruses. Funding Agence Française de Développement. Additional; Institut Pasteur du Laos, Institute Pasteur, Paris and Luxembourg Ministry of Foreign and European Affairs (“PaReCIDS II”).
- Published
- 2021